Biogen Idec Issues Statement on U.S. Approval of AMPYRA™
News Jan 25, 2010
Biogen Idec has issued the following statement regarding the United States (U.S.) Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. The U.S. FDA approval was granted on January 22, 2010.
AMPYRA will be marketed in the U.S by Acorda Therapeutics, Inc. AMPYRA is an extended release tablet formulation of the investigational drug dalfampridine. Biogen Idec will commercialize fampridine as a prolonged release tablet in markets outside of the U.S.
“For people with MS, impaired walking ability is one of the most common and concerning aspects of the disease,” said Alfred Sandrock, MD, PhD, senior vice president, Neurology Research and Development, Biogen Idec. “AMPYRA may be an important therapy in reducing the impact of this debilitating condition.”
“We congratulate our partner, Acorda Therapeutics, on this important achievement and look forward to working with regulators outside of the U.S. to make this therapy available to all people living with MS.”
On 12 January 2010, Biogen Idec announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for prolonged release fampridine tablets for the improvement of walking ability in adult patients with multiple sclerosis (MS). The company also has filed a New Drug Submission (NDS) to Health Canada.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
New Speakers from Roche and Imperial College London Announced for SMi’s ADMET EventNews
SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.READ MORE
Comments | 1 ADD COMMENT
Gail Holy | Apr 10, 2018
As a sign of gratitude for how my son was cured from autism, i decided to reach out to those still suffering from Autism spectrum. My son suffered autism for 7 years and 4 months, it was really tough and heartbreaking for me because he was my all and the symptoms were terrible, he always have difficulty with communication not verbal, and he always complain of poor eye contact, hurt his self, likes music so much. We tried various therapies prescribed by our neurologist but none could cure him. Not until a day when I searched for a cure online and i saw different testimonies of how people are thanking and praising Dr Alwan who has cured their autistic children and so many others with Fallopian tube blockage, infections and diseases problems, and they all left the email of the doctor who had the cure to autism . I never imagined autism has a natural cure but i have no other choice than to contact Dr Alwan and he assured me my son will be fine and then asked me to purchase his autism herbs which i did. Few days later I got the herbal medication he recommended and also gave me instructions and guild lines on how it used. Behold it was amazing, before 2 weeks time i began to see different changes on my son now is perfectly okay, even up till this moment he is so full of life. Autism has a cure and it is an herbal cure contact the doctor for more info on (firstname.lastname@example.org) on how to get cured of your autistic child. Thanks for reading my testimony.